Stubbs Alderton & Markiles client Research Solutions, a SaaS provider of workflow efficiency solutions for R&D-driven organizations, announced this month that Nasdaq approved its application to have its common stock listed on the Nasdaq Capital Market. The Nasdaq Capital Market is focused on its core purpose for those companies listed — capital raising. Research Solutions commence trading on Nasdaq under the symbol “RSSS” on March 23, 2020.
To read the full press release visit here: http://researchsolutions.investorroom.com/2020-03-19-Research-Solutions-Receives-Nasdaq-Listing-Approval
Research Solutions, Inc. (RSSS) provides workflow efficiency solutions for R&D-driven organizations in life sciences, technology, and academia worldwide. Its Software-as-a-Service platform provides tools or “Gadgets” that allow users to discover, access, manage and collaborate around science, technology and medical (STM) content and data. Its customers range from 70 percent of the top 25 global pharmaceutical companies to emerging small and medium-sized businesses. Research Solutions generates recurring revenue from subscriptions to its SaaS platform and transactional revenue from the sale of STM content. For more information, visit www.researchsolutions.com.